Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.

Abstract

nib, with similar findings. Exceptionally different cutaneous adverse effects have been described as keratoacanthomas, squamous cell carcinoma, follicular-based papular eruption, vasculitis, inflammatory actinic keratosis, skin erosion, multiform exudative erythema, follicular hyperplasia on the face, eruptive nevus, yellow skin discoloration and dry skin… (More)
DOI: 10.1111/j.1365-4632.2010.04526.x

Cite this paper

@article{Vergou2010CentralRV, title={Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.}, author={Theognosia Vergou and Aikaterini Evangelia Moustou and Apostolos Maniateas and Alexander J. Stratigos and Andreas D Katsambas and Christina V. Antoniou}, journal={International journal of dermatology}, year={2010}, volume={49 10}, pages={1215-7} }